Jushi Holdings Applies for DEA Registration of State-Licensed Medical Cannabis Operations
Cannabis operator Jushi Holdings (JUSH.CN) has submitted applications to the U.S. Drug Enforcement Administration to register certain state-licensed medical marijuana operations under a federal framework established following the rescheduling of medical marijuana to schedule III, the company said Thursday.The process allows applicants to seek federal registration in connection with the manufacture, distribution, and dispensing of Schedule III medical cannabis products, while relying on existing state medical licenses, Jushi noted.For operators that submit applications within the initial 60-day filing window, registrations may be granted on an expedited basis unless otherwise notified by the DEA, it added.Jushi believes the framework reflects growing federal recognition of state medical cannabis programs and provides a pathway toward greater alignment between state and federal regulation."We are focused on operating at the highest regulatory standards and believe this process represents a meaningful step toward a more integrated and transparent national framework for medical cannabis," Chief Executive Officer Jim Cacioppo said.
